| For: | Gao SJ, Zhang L, Lu W, Wang L, Chen L, Zhu Z, Zhu HH. Interleukin-18 genetic polymorphisms contribute differentially to the susceptibility to Crohn’s disease. World J Gastroenterol 2015; 21(28): 8711-8722 [PMID: 26229413 DOI: 10.3748/wjg.v21.i28.8711] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i28/8711.htm |
| Number | Citing Articles |
| 1 |
Jianrong Shi, Lin He, Huiwen Zheng, Wei Li, Shuangshuang Huang, Yunling Li, Ran Tao. Association of IL-4 and IL-18 genetic polymorphisms with atopic dermatitis in Chinese children. Frontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1202100
|
| 2 |
Muhammad Shahid Nadeem, Vikas Kumar, Fahad A. Al-Abbasi, Mohammad Amjad Kamal, Firoz Anwar. Risk of colorectal cancer in inflammatory bowel diseases. Seminars in Cancer Biology 2020; 64 doi: 10.1016/j.semcancer.2019.05.001
|
| 3 |
Wenjie Liu, Chunhui Wang, Lijuan Tang, Hui Yang. Associations between Gene Polymorphisms in Pro-inflammatory Cytokines and the Risk of Inflammatory Bowel Disease: A Meta-analysis. Immunological Investigations 2021; 50(8) doi: 10.1080/08820139.2020.1787438
|
| 4 |
Yuehong Chen, Yali Ye, Huan Liu, Zhongling Luo, Qianwei Li, Qibing Xie, Baohui Xu. Interleukin‐18 Gene Polymorphisms and Rheumatoid Arthritis Susceptibility: An Umbrella Review of Meta‐Analyses. Journal of Immunology Research 2024; 2024(1) doi: 10.1155/2024/6631033
|
| 5 |
Michelle A. Williams, Amy O'Callaghan, Sinéad C. Corr. IL-33 and IL-18 in Inflammatory Bowel Disease Etiology and Microbial Interactions. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01091
|
| 6 |
Aseel Kariem Al-Sultany, Kassim Abdulla Hamza Al-Morshidy. Single nucleotide polymorphism of IL-18 gene and resistin gene in children infection with Entamoeba histolytica. Medical Journal of Babylon 2023; 20(4) doi: 10.4103/MJBL.MJBL_70_23
|
| 7 |
Jiarui Mi, Zhengye Liu, Shengduo Pei, Xia Wu, Nan Zhao, Lingjuan Jiang, Zhenjie Zhang, Xiaoyin Bai. Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease. International Immunopharmacology 2022; 110 doi: 10.1016/j.intimp.2022.109020
|
| 8 |
Hung-Yu Chiang, Hsueh-Han Lu, Janaki N. Sudhakar, Yu-Wen Chen, Nien-Shin Shih, Yi-Ting Weng, Jr-Wen Shui. IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence. Nature Communications 2022; 13(1) doi: 10.1038/s41467-022-28478-3
|
| 9 |
Yuhang Wang, Joyce Z. Gao, Taylor Sakaguchi, Thorsten Maretzky, Prajwal Gurung, Nandakumar S. Narayanan, Sarah Short, Yiqin Xiong, Zizhen Kang. LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2–GSDMD Axis-Mediated Gut Inflammation. Cells 2024; 13(7) doi: 10.3390/cells13070565
|
| 10 |
Emmanuel Somm, Elodie Perroud, Yunju Jo, Karina Lindner, Frédérique Ino, Sophie A. Montandon, Christelle Veyrat-Durebex, Franck Bontems, Florian Visentin, Nadia Gaïa, Vladimir Lazarevic, Anne-Claude Gavin, Jacques Schrenzel, Dongryeol Ryu, Karim Gariani, Cem Gabay, François R. Jornayvaz. Interleukin-18 binding protein deficiency results in gut microbiota dysbiosis and aggravated diet-induced MASH in mice. JHEP Reports 2026; 8(1) doi: 10.1016/j.jhepr.2025.101629
|
| 11 |
Monika S Patil, Priyanka M Mane, Shivani R Kale, Sonika S Patil, Satish V Kakade, Satish Patil. Association of Interleukin-4 (rs224320), Interleukin-18 (rs1946518 and rs187238), and Tumor Necrosis Factor Receptor 2 (rs1061622) Gene Polymorphisms With Type 2 Diabetes Mellitus in a Rural South-Western Maharashtra Population. Cureus 2026; doi: 10.7759/cureus.110048
|
| 12 |
Vijay A.K. Rathinam, Francis Ka-Ming Chan. Inflammasome, Inflammation, and Tissue Homeostasis. Trends in Molecular Medicine 2018; 24(3) doi: 10.1016/j.molmed.2018.01.004
|
| 13 |
Chang Liu, Jing Yang. Enteric Glial Cells in Immunological Disorders of the Gut. Frontiers in Cellular Neuroscience 2022; 16 doi: 10.3389/fncel.2022.895871
|
| 14 |
Yu Zhen, Hu Zhang. NLRP3 Inflammasome and Inflammatory Bowel Disease. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00276
|
| 15 |
Yujie Zhou, Songyan Yu, Wenyong Zhang. NOD-like Receptor Signaling Pathway in Gastrointestinal Inflammatory Diseases and Cancers. International Journal of Molecular Sciences 2023; 24(19) doi: 10.3390/ijms241914511
|
| 16 |
Jaika M. I. Rutgrink, Anje A. te Velde. From Diet to Inflammasome: Ultra-Processed Foods as Upstream Drivers of NLRP3-Mediated Intestinal Inflammation in Inflammatory Bowel Disease. Immuno 2026; 6(2) doi: 10.3390/immuno6020024
|
| 17 |
David Illig, Daniel Kotlarz. Dysregulated inflammasome activity in intestinal inflammation – Insights from patients with very early onset IBD. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1027289
|
| 18 |
Zhi-Jun Dai, Xing-Han Liu, Meng Wang, Yan Guo, Wenge Zhu, Xiao Li, Shuai Lin, Tian Tian, Kang Liu, Yi Zheng, Peng Xu, Tianbo Jin, Xiaopeng Li. IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control study. Oncotarget 2017; 8(46) doi: 10.18632/oncotarget.18531
|
| 19 |
Megha Singhal, Vipin Arora, Hee-Jeong Im. Gastrointestinal disorders-induced pain. Gene Reports 2020; 18 doi: 10.1016/j.genrep.2019.100580
|
| 20 |
Kohei Wagatsuma, Hiroshi Nakase. Contradictory Effects of NLRP3 Inflammasome Regulatory Mechanisms in Colitis. International Journal of Molecular Sciences 2020; 21(21) doi: 10.3390/ijms21218145
|
| 21 |
|
| 22 |
Yahya Jaber Al-ardawy, Ali Hmood Al-Saadi, Mahmoud A. Alkindy, Ammar M. Al-Lsawi, Maksad A. Fadheel. Study of the relationship between genetic variants of IL-18 and the occurrence of inflammatory bowel disease. Egyptian Journal of Medical Human Genetics 2024; 25(1) doi: 10.1186/s43042-024-00555-w
|
| 23 |
Emmanuel Somm, François R. Jornayvaz. Interleukin-18 in metabolism: From mice physiology to human diseases. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.971745
|
| 24 |
Koubun Yasuda, Kenji Nakanishi, Hiroko Tsutsui. Interleukin-18 in Health and Disease. International Journal of Molecular Sciences 2019; 20(3) doi: 10.3390/ijms20030649
|
| 25 |
Sanaz Keshavarz Shahbaz, Khadijeh Koushki, Seyed Hassan Ayati, Abigail R. Bland, Evgeny E. Bezsonov, Amirhossein Sahebkar. Inflammasomes and Colorectal Cancer. Cells 2021; 10(9) doi: 10.3390/cells10092172
|
| 26 |
Viviana Scalavino, Emanuele Piccinno, Gianluigi Giannelli, Grazia Serino. Inflammasomes in Intestinal Disease: Mechanisms of Activation and Therapeutic Strategies. International Journal of Molecular Sciences 2024; 25(23) doi: 10.3390/ijms252313058
|
| 27 |
Xiao-Meng Wang, Ci Yang, Yin Zhao, Zhi-Gao Xu, Wei Yang, Peng Wang, Dandan Lin, Bin Xiong, Jing-Yuan Fang, Chen Dong, Bo Zhong. The deubiquitinase USP25 supports colonic inflammation and bacterial infection and promotes colorectal cancer. Nature Cancer 2020; 1(8) doi: 10.1038/s43018-020-0089-4
|
| 28 |
Wei Yang, Hong‐Peng Dong, Peng Wang, Zhi‐Gao Xu, Jiahuan Xian, Jiachen Chen, Hai Wu, Yang Lou, Dandan Lin, Bo Zhong. IL‐36γ and IL‐36Ra Reciprocally Regulate Colon Inflammation and Tumorigenesis by Modulating the Cell–Matrix Adhesion Network and Wnt Signaling. Advanced Science 2022; 9(10) doi: 10.1002/advs.202103035
|